Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.10 is 24% above its 5-year average of -1.45, around the middle of its 5-year range (-2.45–-0.45).
16.03% above its 12-month average of -1.31.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.21.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 29 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T12:00:55.906Z. Historical observations retain their original dates. Historical series through 2022-11-08.
EARNINGS PER SHARE (EPS)
-1.10
EARNINGS PER SHARE (EPS) AVG TTM
-1.31
EARNINGS PER SHARE (EPS) AVG 3Y
-1.45
EARNINGS PER SHARE (EPS) AVG 5Y
-1.45
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+16.03%
CURRENT VS 3Y AVG
+24.14%
CURRENT VS 5Y AVG
+24.14%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Alector, Inc.
Market Cap
$220.94M
Earnings Per Share (EPS)
-1.10
TTM Avg
-1.31
3Y Avg
-1.45
5Y Avg
-1.45
Market Cap
$218.42M
Earnings Per Share (EPS)
0.38
TTM Avg
0.11
3Y Avg
-0.10
5Y Avg
-0.19
Market Cap
$206.61M
Earnings Per Share (EPS)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$236.56M
Earnings Per Share (EPS)
-3.17
TTM Avg
-5.64
3Y Avg
-13.77
5Y Avg
-18.37
Market Cap
$239.45M
Earnings Per Share (EPS)
-2.38
TTM Avg
-2.11
3Y Avg
-1.81
5Y Avg
-1.81
Market Cap
$202.05M
Earnings Per Share (EPS)
-1.07
TTM Avg
-1.44
3Y Avg
-2.10
5Y Avg
-1.78
Market Cap
$244.25M
Earnings Per Share (EPS)
-0.11
TTM Avg
-0.18
3Y Avg
-0.30
5Y Avg
-0.87
Market Cap
$245.65M
Earnings Per Share (EPS)
-0.43
TTM Avg
-0.62
3Y Avg
-0.66
5Y Avg
-0.59
Market Cap
$248.21M
Earnings Per Share (EPS)
-1.54
TTM Avg
-1.32
3Y Avg
-0.98
5Y Avg
-0.74
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alector, Inc. (ALEC) | $220.94M | -1.10 | -1.31 | -1.45 | -1.45 |
| Compugen Ltd. (CGEN)vs › | $218.42M | 0.38 | 0.11 | -0.10 | -0.19 |
| Electra Therapeutics Inc. (ETRA)vs › | $206.61M | N/A | N/A | N/A | N/A |
| Biodesix, Inc. (BDSX)vs › | $236.56M | -3.17 | -5.64 | -13.77 | -18.37 |
| BioAge Labs Inc. (BIOA)vs › | $239.45M | -2.38 | -2.11 | -1.81 | -1.81 |
| AN2 Therapeutics, Inc. (ANTX)vs › | $202.05M | -1.07 | -1.44 | -2.10 | -1.78 |
| Akebia Therapeutics, Inc. (AKBA)vs › | $244.25M | -0.11 | -0.18 | -0.30 | -0.87 |
| Galectin Therapeutics Inc. (GALT)vs › | $245.65M | -0.43 | -0.62 | -0.66 | -0.59 |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $248.21M | -1.54 | -1.32 | -0.98 | -0.74 |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $192.97M | -0.99 | -0.66 | -3.05 | -5.28 |
Trailing EPS (TTM)
$-1.10
Forward EPS (Est.)
$-0.86
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.39 |
| 2024-12-31 | -1.23 |
| 2023-12-31 | -1.56 |
| 2022-12-31 | -1.62 |
| 2021-12-31 | -0.45 |
| 2020-12-31 | -2.45 |
| 2019-12-31 | -1.62 |
| 2018-12-31 | -0.76 |
| 2017-12-31 | -0.63 |
| 2016-12-31 | -1.78 |
